Core Viewpoint - The company is proceeding with the repurchase and cancellation of restricted stocks and stock options as part of its 2024 incentive plan due to the departure of several incentive recipients [2][3]. Group 1: Incentive Plan Progress - The incentive plan draft was approved by the Compensation and Assessment Committee on April 19, 2024, followed by approvals from the board and supervisory committee on April 23, and the annual shareholders' meeting on May 17, 2023 [2]. - The first exercise conditions for stock options were approved by the Compensation and Assessment Committee on April 17, 2025 [2]. Group 2: Repurchase and Cancellation Details - A total of 28,000 restricted stocks and 42,500 stock options will be repurchased and canceled due to five incentive recipients leaving the company [2]. - The repurchase price is set at 9.92 yuan per share, with funding sourced from the company's own funds [2]. - This repurchase and cancellation will not affect the company's stock distribution or the implementation of the incentive plan, nor will it have a significant impact on the company's operating performance [2]. Group 3: Information Disclosure - The company will timely announce the resolutions from the board meeting and the details regarding the repurchase and cancellation of stocks and options [3]. - The legal opinion confirms that necessary approvals have been obtained, although the repurchase of restricted stocks still requires shareholder meeting approval [3].

Core Points - The company has completed its share repurchase plan, acquiring a total of 20,200,043 shares for future employee stock ownership plans [4][5][8] - The board of directors has approved the 2025 semi-annual report, confirming that it accurately reflects the company's operational status and financial condition [8][9] - The company did not distribute cash dividends or issue new shares during the reporting period [3][4] Company Overview - The company is Zhejiang George White Garment Co., Ltd., with stock code 002687 [6] - The board meeting was held on August 26, 2025, with all directors present, ensuring compliance with legal requirements [7][8] Financial and Operational Highlights - The company has not changed its controlling shareholder or actual controller during the reporting period [5] - The company has no preferred shareholders or related bond issues during the reporting period [4][5] Important Resolutions - The board approved the share repurchase plan on February 5, 2024, and decided to terminate the repurchase ahead of schedule due to the completion of the planned buyback [4][8] - The board also approved the release of restrictions on 719,122 shares for 52 eligible incentive recipients as part of the 2021 restricted stock incentive plan [4][8]

Core Viewpoint - The company has announced the achievement of the first vesting conditions for the second category of restricted stock under the seventh equity incentive plan, allowing for the allocation of shares to eligible participants [1][4]. Summary by Sections 1. Overview of the Seventh Equity Incentive Plan - The company plans to grant a total of up to 34.76 million shares, with the first grant not exceeding 31.28 million shares, accounting for approximately 1.17% of the total share capital of 2,678.14 million shares [1]. - The first grant date is set for September 23, 2024, with a grant price of 42.87 CNY per share [1]. 2. Vesting Conditions Achievement - The first vesting period is defined as the first trading day after 12 months from the grant date until the last trading day within 24 months [1]. - The company has confirmed that the conditions for the first vesting period have been met, allowing for the allocation of shares to 12 eligible participants [4][6]. 3. Performance Assessment - The company’s revenue for 2024 is reported at approximately 37.04 billion CNY, indicating compliance with the performance assessment criteria [2][3]. - Individual performance assessments categorize participants into five levels, with 12 participants meeting the criteria for full vesting [3][4]. 4. Financial Impact - The allocation of shares will not significantly impact the company's financial status or operational results, as the shares are sourced from the company's repurchased stock [5]. - The total number of shares held in the repurchase account will decrease by 63,500 shares due to this allocation [5]. 5. Legal Compliance - The company has obtained necessary approvals and authorizations for the equity incentive plan, ensuring compliance with relevant laws and regulations [7].

Core Viewpoint - Jiangxi Sanxin Medical Technology Co., Ltd. has announced the lifting of restrictions on the first phase of its 2024 restricted stock incentive plan, allowing for the circulation of 52,239,752.5 shares, which accounts for 0.7369% of the total shares [1] Summary by Sections Incentive Plan Approval Process - The company held meetings to approve the relevant proposals related to the 2024 restricted stock incentive plan, including the draft and management measures [1][2][3] - The independent directors collected proxy votes from shareholders for the incentive plan, which was approved at the 2024 first extraordinary general meeting [3] Conditions for Lifting Restrictions - The first lifting of restrictions will occur on September 1, 2025, following the completion of the stock grant registration on August 30, 2024 [5] - The board confirmed that the conditions for lifting restrictions have been met, including no negative audit opinions and compliance with legal regulations [5][6] Performance Targets - The company achieved a net profit of 209.8692 million yuan for 2024, a 15.35% increase from 2023, meeting the performance targets set for the incentive plan [8] - The revenue for 2024 was reported at 1,500.4384 million yuan, reflecting a growth of 15.41% compared to the previous year [8] Stock Circulation Arrangement - A total of 112 individuals will have their restricted stocks lifted, with 384.9575 million shares available for circulation, representing 48.45% of the total granted shares [10] - The stock lifting will include 6 directors and senior management, who will have 50% of their granted shares released [10] Changes in Stock Structure - Following the lifting of restrictions, the total share capital remains at 522,397,525 shares, with no shares under restriction [12][13] - The company will repurchase and cancel a total of 313,250 shares due to non-compliance with lifting conditions by some incentive recipients [12]

证券代码：600388 证券简称：龙净环保 公告编号：2025-048 福建龙净环保股份有限公司 关于向2024年股票期权激励计划激励对象授予 预留股票期权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 预留授予日：2025 年 8 月 25 日。 办理公司 2024 年员工持股计划及股票期权激励计划相关事宜的议案》的授权， 会议，审议通过了《关于向 2024 年股票期权激励计划激励对象首次授予股票期 权的议案》，公司监事会对首次授予激励对象名单再次进行了核实并发表了核查 意见。 算有限责任公司上海分公司完成相关登记手续。 ? 预留授予数量：360 万股。 ? 预留授予人数：133 人。 ? 预留授予的行权价格：11.95 元/股。 福建龙净环保股份有限公司（以下简称"公司"）2024 年股票期权激励计 划（以下简称"本激励计划"）的预留股票期权授予条件已成就。根据公司 2025 年第二次临时股东会的授权，公司于 2025 年 8 月 25 日召开第十届董事会第十六 次会议和第十届监事会第十二次会议 ...

的情形： （1）最近 12 个月内被证券交易所认定为不适当人选； （2）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； 江苏赛福天集团股份有限公司董事会薪酬与考核委员会 关于公司2025年限制性股票激励计划授予激励对象名单 （授予日）的核查意见 江苏赛福天集团股份有限公司（以下简称"公司"）董事会薪酬与考核委员会 依据《公司法》《证券法》《上市公司股权激励管理办法》（以下简称"《管理办 法》"）等有关规定，对《江苏赛福天集团股份有限公司 2025 年限制性股票激 励计划》（以下简称"本次激励计划"或"《激励计划》"）授予激励对象名单 （授予日） 进行了核查，发表核查意见如下： 激励的其他人员。激励对象名单及其获授限制性股票的情况除经公司第五届董 事会第十八次会议审议调整事项外，均与公司 2025 年第一次临时股东会审议 通过的激励计划一致。 （5）法律法规规定不得参与上市公司股权激励的； （6）中国证监会认定的其他情形。 其中不包括董事、独立董事、监事、高级管理人员、单独或合计持有公司5%以 上股份的股东、公司实际控制人及其配偶、父母、子女。 次激励计划的授予条件已成就。 综上所述，董事会薪酬与 ...

Core Viewpoint - The company has announced the achievement of the vesting conditions for the second vesting period of its 2023 restricted stock incentive plan, allowing for the allocation of 1,247,200 shares to eligible participants, representing 1.04% of the total share capital [1][10][14]. Summary by Sections 1. Overview of the 2023 Restricted Stock Incentive Plan - The plan involves the issuance of restricted stock to certain employees, excluding independent directors and supervisors, with a total of 1,247,200 shares allocated for the second vesting period [1][2]. - The plan's effective period is up to 48 months from the grant date, with specific vesting arrangements outlined for three periods: 30% for the first period, 40% for the second, and 30% for the third [2][3]. 2. Vesting Conditions and Performance Targets - The vesting conditions require a minimum revenue growth of 20% for 2023, 30% for 2024, and 40% for 2025, based on 2022 performance [4][13]. - Personal performance assessments will determine the actual number of shares vested, with ratings ranging from excellent to unsatisfactory affecting the vesting percentage [6][13]. 3. Approval and Compliance - The plan has undergone necessary approvals from the board and supervisory committee, confirming compliance with relevant regulations and internal policies [10][15]. - A legal opinion has been provided affirming that the plan's implementation adheres to applicable laws and regulations [16]. 4. Financial Impact - The allocation of 1,247,200 shares will increase the company's total share capital from 120,202,400 shares to 121,449,600 shares, which may dilute earnings per share and net asset return but is not expected to significantly impact the company's financial status [17][18]. 5. Documentation and Records - Key documents related to the board and supervisory committee meetings, as well as legal opinions, are available for review [18].

Core Points - The company has approved the cancellation of stock options under the seventh equity incentive plan due to the departure of 23 employees and performance issues of 153 employees [1][4][5] Group 1: Equity Incentive Plan Overview - The seventh equity incentive plan allows for the grant of up to 34.76 million shares, with an initial grant of 31.28 million shares to 1,225 individuals, representing 1.17% of the company's total share capital of 2,678.14 million shares [1][2] - The initial grant of stock options was set at 31 million shares with an exercise price of 42.87 yuan per share [1][2] - Following adjustments, the number of stock options granted was reduced to 30.89 million shares for 1,146 individuals, and later to 30.69 million shares for 1,139 individuals due to further departures and withdrawals [2][3] Group 2: Cancellation of Stock Options - A total of 625,876 stock options will be canceled, including 528,000 options from 23 departing employees and 97,876 options from 153 employees who did not meet performance criteria [4][5] - The cancellation of stock options will not significantly impact the company's financial status or operational performance [5] Group 3: Accounting Treatment - The cancellation of stock options will lead to adjustments in capital reserves and current expense costs according to relevant accounting standards [4]

法律意见书 广州市天河区珠江东路 32 号利通广场 29 楼 2901 室 邮编/Zip Code:510623 电话/Tel:86-020-37392666 传真/Fax:86-020-37392826 电子邮箱/E-mail：kdgzlaw@163.com 北京 天津 上海 深圳 广州 西安 沈阳 南京 杭州 海口 菏泽 成都 苏州 呼和浩特 长沙 厦门 郑州 香港 武汉 北京市康达（广州）律师事务所 关于深圳市汇川技术股份有限公司 第七期股权激励计划首次授予第二类限制性股票第一个归属期 归属条件成就、首次授予股票期权第一个行权期行权条件成就 暨注销部分股票期权的 法 律 意 见 书 康达(广州)法意字【2025】第 0235 号 二〇二五年八月 法律意见书 北京市康达（广州）律师事务所 关于深圳市汇川技术股份有限公司 第七期股权激励计划首次授予第二类限制性股票第一个归属期 归属条件成就、首次授予股票期权第一个行权期行权条件成就暨 注销部分股票期权的 法律意见书 康达(广州)法意字【2025】第 0235 号 致：深圳市汇川技术股份有限公司 北京市康达（广州）律师事务所接受深圳市汇川技术股份有限公司（以下 ...

Core Viewpoint - The company has announced adjustments to the grant price and quantity of its 2023 restricted stock incentive plan, following necessary procedures and approvals [1][2][3]. Group 1: Procedures and Approvals - The company held multiple meetings, including the sixth board meeting and the sixth supervisory board meeting, to review and approve the incentive plan and related proposals [1][2][3]. - The company conducted an internal public notice period for the incentive plan's designated recipients, during which no objections were raised [2][3]. - The second extraordinary general meeting of shareholders approved the incentive plan and related matters on September 7, 2023 [3][4]. Group 2: Adjustments to Grant Price and Quantity - The grant price of the restricted stock has been adjusted from 4.32 yuan per share to approximately 3.09 yuan per share due to capital reserve transfers and stock dividends [5][6]. - The number of shares granted but not yet vested has been adjusted from 39.29 million shares to 55.01 million shares, reflecting the same capital reserve transfers and stock dividends [5][6]. Group 3: Impact and Compliance - The adjustments comply with relevant regulations and will not materially affect the company's financial status or operating results [6]. - The board's compensation and assessment committee has agreed that the adjustments do not harm the interests of the company or its shareholders [6][7]. Group 4: Legal and Financial Advisory Opinions - Legal opinions confirm that the adjustments and related actions have received necessary approvals and comply with applicable laws and regulations [7]. - Independent financial advisors have reported that the adjustments have followed necessary review procedures and disclosure obligations [7].